These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 2045860
1. Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study. Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. J Clin Oncol; 1991 Jul; 9(7):1204-9. PubMed ID: 2045860 [Abstract] [Full Text] [Related]
3. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K. J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [Abstract] [Full Text] [Related]
6. Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246. Press OW, LeBlanc M, O'Rourke TJ, Gagnet S, Chapman RA, Balcerzak SP, Fisher RI. J Clin Oncol; 1998 Feb; 16(2):574-8. PubMed ID: 9469343 [Abstract] [Full Text] [Related]
7. Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report. Ringenberg QS, Propert KJ, Muss HB, Weiss RB, Schilsky RL, Modeas C, Perry MC, Norton L, Green M. Invest New Drugs; 1990 May; 8(2):221-6. PubMed ID: 2166722 [Abstract] [Full Text] [Related]
11. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma]. Masaoka T, Ogawa M, Inoue K, Sanpi K, Kuraishi Y, Toki H, Tamura K, Takagi T, Shibata A, Hirano M, Ezaki K, Shirakawa S, Matsuda T, Kimura I. Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478 [Abstract] [Full Text] [Related]
12. Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F. Clin Cancer Res; 2004 Aug 15; 10(16):5432-8. PubMed ID: 15328181 [Abstract] [Full Text] [Related]
16. Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas. Borchmann P, Morschhauser F, Parry A, Schnell R, Harousseau JL, Gisselbrecht C, Rudolph C, Wilhelm M, Günther H, Pfreundschuh DM, Camboni G, Engert A. Haematologica; 2003 Aug 15; 88(8):888-94. PubMed ID: 12935976 [Abstract] [Full Text] [Related]
17. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A, Berg R. Laryngoscope; 2001 Sep 15; 111(9):1565-9. PubMed ID: 11568605 [Abstract] [Full Text] [Related]
20. Esorubicin (4'-deoxydoxorubicin, NSC 267469) in advanced breast cancer. A phase II study of the CALGB. Muss HB, Van Echo D, Korzun AH, Henderson IC, Campbell T, Vogelzang NJ, Rice MA, Wood W. Am J Clin Oncol; 1990 Jun 15; 13(3):233-7. PubMed ID: 2346128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]